Abstract

Essential medicines are defined as those that “satisfy the priority health care needs of the population” and selected with due regard to public health relevance based on their efficacy, safety, and comparative cost-effectiveness.1 They are intended to be accessible within the context of functioning health systems in adequate quantities, in the appropriate dosage forms, with ensured quality and adequate information, and at a price the individual and the community can afford. The World Health Organization calls for “improved access to essential, high-quality, safe, effective and affordable medicines and health products.”2 However, nearly 2 billion people have no access to essential medicines globally, particularly in low-income countries (LICs) and lower middle–income countries (LMICs).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.